NewsBenzingaHinge Health eleva su guía de ventas para el ejercicio fiscal 2026 de $856.000M-$860.000M a $879.000M-$881.000M frente a una estimación de $861.558M Hinge Health eleva su guía de ventas para el ejercicio fiscal 2026 de $856.000M-$860.000M a $879.000M-$881.000M frente a una estimación de $861.558M Benzinga 2026.11.02 21:11 (GMT+0) Open on Benzinga Other news StoneX Maintains Buy on Rivian Automotive, Lowers Price Target to $20 Amer Sports Unleashes $1 Billion Buyback, Raises 2026 Outlook EXCLUSIVE: Tesla Still Rules Leveraged ETFs, but Anthropic IPO and Micron’s Rise Signal What’s Next StoneX Reiterates Hold on iQIYIto Hold StoneX Maintains Buy on Baidu, Lowers Price Target to $125 Veru Presents New Results At ObesityWeek; Adding Enobosarm Preserved Lean Mass And Stair Climb Physical Function In Older Patients ≥65 Years With Obesity Receiving Semaglutide
Veru Presents New Results At ObesityWeek; Adding Enobosarm Preserved Lean Mass And Stair Climb Physical Function In Older Patients ≥65 Years With Obesity Receiving Semaglutide